Magenta Therapeutics

📍 Cambridge, United States🗓 Founded 2016👥 81 employees
Biotechnology🌐 magentatx.com
Website LinkedIn
Headquartered in Cambridge, Mass., Magenta Therapeutics (Nasdaq:MGTA) is a clinical-stage biotechnology company developing therapeutics to reset the immune system in order to cure more patients with devastating and life-threatening diseases. This immune reset approach can be applied through stem cell transplant to multiple diseases, including autoimmune diseases, such as multiple sclerosis and systemic sclerosis; blood cancers, such as acute myeloid leukemia; and genetic diseases, such as sickle cell disease. Magenta’s comprehensive approach to precision immune system reset will transform many aspects of the transplant process, aiming to make it more effective and safer.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Magenta Therapeutics founded?
Magenta Therapeutics was founded in 2016.
What industry is Magenta Therapeutics in?
Magenta Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Magenta Therapeutics based?
Magenta Therapeutics is headquartered in Cambridge, United States.